123 related articles for article (PubMed ID: 22914965)
1. Inhibitory effects of baicalin on orthotopic xenografts of colorectal cancer cells that are deficient in a mismatch repair gene in nude mice.
Yang BL; Chen HJ; Chen YG; Gu YF; Zhang SP; Lin Q; Sun Y
Int J Colorectal Dis; 2013 Apr; 28(4):547-53. PubMed ID: 22914965
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Baicalin on an orthotopic transplantation mouse model of mismatch repair gene deficient colorectal cancer].
Yang BL; Chen HJ; Chen YG; Gu YF; Zhang SP; Lin Q; Zhu P
Zhonghua Wai Ke Za Zhi; 2012 Sep; 50(9):843-7. PubMed ID: 23157964
[TBL] [Abstract][Full Text] [Related]
3. Baicalin and its emerging antineoplastic effects in systemic malignancies besides colorectal carcinomas.
Kapoor S
Int J Colorectal Dis; 2013 Aug; 28(8):1169-70. PubMed ID: 23114477
[No Abstract] [Full Text] [Related]
4. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
Qi Y; Schoene NW; Lartey FM; Cheng WH
J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
[TBL] [Abstract][Full Text] [Related]
5. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines.
Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR
Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533
[TBL] [Abstract][Full Text] [Related]
6. Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?
Lin AY; Lin E
J Hematol Oncol; 2015 Nov; 8():124. PubMed ID: 26542241
[TBL] [Abstract][Full Text] [Related]
7. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
[TBL] [Abstract][Full Text] [Related]
8. The BRAF mutation in MLH1-deficient colorectal cancer.
Mahesh SA
Clin Adv Hematol Oncol; 2013 Apr; 11(4):234-6. PubMed ID: 23604240
[No Abstract] [Full Text] [Related]
9. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
10. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
[TBL] [Abstract][Full Text] [Related]
11. [Effects of baicalin on HL-60 cell xenografts in nude mice and its mechanism].
Zheng J; Hu JD; Huang Y; Chen YY; Li J; Chen BY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1066-71. PubMed ID: 23114120
[TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells.
Iwaizumi M; Tseng-Rogenski S; Carethers JM
Cancer Biol Ther; 2011 Oct; 12(8):756-64. PubMed ID: 21814034
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperthermia on Hsp27 (HSPB1), Hsp72 (HSPA1A) and DNA repair proteins hMLH1 and hMSH2 in human colorectal cancer hMLH1-deficient and hMLH1-proficient cell lines.
Nadin SB; Cuello-Carrión FD; Sottile ML; Ciocca DR; Vargas-Roig LM
Int J Hyperthermia; 2012; 28(3):191-201. PubMed ID: 22515340
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
Morioka T; Miyoshi-Imamura T; Blyth BJ; Kaminishi M; Kokubo T; Nishimura M; Kito S; Tokairin Y; Tani S; Murakami-Murofushi K; Yoshimi N; Shimada Y; Kakinuma S
Cancer Sci; 2015 Mar; 106(3):217-26. PubMed ID: 25529563
[TBL] [Abstract][Full Text] [Related]
15. Absence of hMLH1 or hMSH2 expression as a stage-dependent prognostic factor in sporadic colorectal cancers.
Park JW; Chang HJ; Park S; Kim BC; Kim DY; Baek JY; Kim SY; Oh JH; Choi HS; Park SC; Jeong SY
Ann Surg Oncol; 2010 Nov; 17(11):2839-46. PubMed ID: 20549564
[TBL] [Abstract][Full Text] [Related]
16. Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice.
Roque-Lima B; Roque CCTA; Begnami MD; Peresi P; Lima ENP; Mello CAL; Coimbra FJ; Chojniak R; Goss Santos T
J Drug Target; 2019 Nov; 27(9):943-949. PubMed ID: 30088428
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the impact of hyperlipidemia on the chemotherapy in colorectal cancer model].
He YS; Jin HY; Zhang JC; Zhou AC
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):583-7. PubMed ID: 23801216
[TBL] [Abstract][Full Text] [Related]
18. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
19. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin.
Fink D; Nebel S; Norris PS; Baergen RN; Wilczynski SP; Costa MJ; Haas M; Cannistra SA; Howell SB
Int J Cancer; 1998 Aug; 77(5):741-6. PubMed ID: 9688308
[TBL] [Abstract][Full Text] [Related]
20. [Mismatch repair gene hMLH1 A655G/A polymorphism and colorectal cancer].
Song L; Zhang XM; Wang DQ; Li JT; Ma GJ; Chen SQ; Zhou JN
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Mar; 13(3):216-8. PubMed ID: 20336543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]